GF
GILD icon

Gerstein Fisher’s Gilead Sciences GILD Stock Holding History

Gerstein Fisher’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$3.55M Sell
44,912
-11,574
-20% -$940K 0.44% 42
2016
Q2 		$4.71M Sell
56,486
-1,259
-2% -$112K 0.62% 25
2016
Q1 		$5.3M Sell
57,745
-2,218
-4% -$200K 0.72% 19
2015
Q4 		$6.07M Sell
59,963
-311
-0.5% -$32.4K 0.85% 18
2015
Q3 		$5.92M Sell
60,274
-283
-0.5% -$31.4K 0.89% 14
2015
Q2 		$7.09M Buy
60,557
+1,640
+3% +$179K 1.15% 8
2015
Q1 		$5.78M Buy
58,917
+3,293
+6% +$334K 0.95% 13
2014
Q4 		$5.27M Buy
55,624
+369
+0.7% +$38.2K 0.86% 17
2014
Q3 		$5.88M Buy
55,255
+603
+1% +$59K 1.03% 10
2014
Q2 		$4.53M Buy
54,652
+758
+1% +$59K 0.86% 14
2014
Q1 		$3.82M Sell
53,894
-4,500
-8% -$353K 0.76% 14
2013
Q4 		$19.6M Buy
58,394
+29,069
+99% +$2.02M 0.73% 32
2013
Q3 		$1.84M Buy
29,325
+1,015
+4% +$60.7K 0.4% 37
2013
Q2 		$1.45M Buy
+28,310
New +$1.48M 0.35% 47

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gerstein Fisher's GILD Position: Q3 2016 in Review

Gerstein Fisher reduced its Gilead Sciences (GILD) stake by 20% in Q3 2016, selling an estimated $940K and leaving 44,912 shares worth $3.55M. The position accounts for 0.44% of the portfolio, ranked #42.

Gerstein Fisher first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. The position peaked at $19.6M in Q4 2013. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Gerstein Fisher held 44,912 shares of Gilead Sciences worth $3.55M as of Q3 2016.
  • Gerstein Fisher sold 11,574 Gilead Sciences shares in Q3 2016, an estimated $940K.
  • Gilead Sciences made up 0.44% of Gerstein Fisher's portfolio in Q3 2016, its #42 holding.
  • Gerstein Fisher first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
  • Gerstein Fisher's Gilead Sciences position peaked at $19.6M in Q4 2013.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.